EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSLOCG00000008711
Gene Symbol: DHCR24
3 Cross references
208 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSLOCG00000005433
Gene Symbol: HMGCR
3 Cross references
270 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSLOCG00000003794
Gene Symbol: PDPK1
3 Cross references
243 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSLOCG00000005223
Gene Symbol: HPD
3 Cross references
204 Possible Orthologues:

5'-Nucleotidase, Ecto (Cd73)

Ensembl ID : ENSLOCG00000016916
Gene Symbol: NT5E
1 Cross references
248 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSLOCG00000018010
Gene Symbol: HTR1B
2 Cross references
245 Possible Orthologues:

5-Hydroxytryptamine Receptor 1e

Ensembl ID : ENSLOCG00000018011
Gene Symbol: HTR1E
4 Cross references
155 Possible Orthologues:

5-Hydroxytryptamine Receptor 1f

Ensembl ID : ENSLOCG00000017418
Gene Symbol: HTR1F
2 Cross references
66 Possible Orthologues:

5-Hydroxytryptamine Receptor 2a

Ensembl ID : ENSLOCG00000010438
Gene Symbol: HTR2A
4 Cross references
219 Possible Orthologues:

5-Hydroxytryptamine Receptor 2a-Like

Ensembl ID : ENSLOCG00000013705
Gene Symbol: LOC102690200
3 Cross references
226 Possible Orthologues:

5-Hydroxytryptamine Receptor 2b

Ensembl ID : ENSLOCG00000004704
Gene Symbol: HTR2B
3 Cross references
204 Possible Orthologues:

5-Hydroxytryptamine Receptor 3a

Ensembl ID : ENSLOCG00000004605
Gene Symbol: HTR3A
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).